Clinical Trials Logo
  1. Home
  2. Cancer
  3. NCT02836392
  4. Details
NCT02836392 Clinical Trial

CRQ Survey Study: Clinical Research Questionnaire of Oncology Patients - A Nationwide Survey

Cancer Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02836392
Other study ID # ICORG 15-43
Secondary ID
Status Completed
Phase N/A
First received June 27, 2016
Last updated August 9, 2017
Start date May 2016
Est. completion date January 2017

Study information
Verified date August 2017
Source Cancer Trials Ireland
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a translational, multicentre questionnaire study. The study design follows that of a cross sectional, quantitative research approach. Data collection will involve self-administered, paper-based questionnaires. The method of data collection allows for a large sample size without major expense. The questionnaires are comprised of several questions examining areas such as demographic details, cancer diagnosis, understanding of the term 'clinical trials', attitudes to personal participation in cancer clinical research and the experience of patients who previously participated in a cancer clinical trial. The study will be opened in all interested hospitals in Ireland following initiation of the study at each site. Questionnaire completion will be seen as implied informed consent and no formal consent will need to be signed by the patient. The paper-based questionnaire responses will be electronically and anonymously recorded in a computer database to facilitate analysis.

Recruitment information / eligibility
Status Completed
Enrollment 1000
Est. completion date January 2017
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Clinical diagnosis of malignancy

- Aged 18 years or older

- Ability to complete the questionnaire or independently or with the help of a friend, relative, or staff member of the oncology department

Exclusion Criteria:

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• Questionnaire

Locations
Country Name City State
Ireland Beaumont Hospital Beaumont Road Dublin
Ireland Bon Secours Hospital Cork
Ireland Cork University Hospital Cork
Ireland Beacon Hospital Dublin
Ireland Mater Misericordiae University Hospital Dublin
Ireland Saint Luke's Hospital Rathgar Dublin
Ireland St James Hospital Dublin
Ireland St Vincent's University Hospital Elm Park Dublin 4
Ireland University Hospital Galway Galway
Ireland Letterkenny General Hospital Letterkenny
Ireland University Hospital Limerick Limerick
Ireland Sligo University Hospital Sligo
Ireland AMNCH Tallaght Dublin 24
Ireland University Hospital Waterford Waterford Co Waterford

Sponsors (1)
Lead Sponsor Collaborator
Cancer Trials Ireland

Country where clinical trial is conducted

Ireland, 

Outcome
Type Measure Description Time frame Safety issue
Primary Oncology patients' understanding of the term 'clinical trials' and their attitudes towards personal participation in cancer clinical research will be evaluated by questionnaire. 1 year
Secondary The patient related factors, including level of education and socioeconomic status that influence their decision regarding participation in a cancer clinical trial (CCT) will be explored by questionnaire. 1 year
Secondary The patients' experience surrounding the discussion regarding CCT participation and their actual experience when enrolled in a CCT will be investigated by questionnaire. 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients